Document Detail


PDCD4 expression in thyroid neoplasia.
MedLine Citation:
PMID:  23212265     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Both the morphogenesis and the molecular pathways of thyroid cancers are controversial. Programmed cell death 4 (PDCD4) is a tumor suppressor gene whose expression is controlled by miR-21. By applying immunohistochemistry for PDCD4 and both quantitative real-time PCR (qRT-PCR) and in situ hybridization for miR-21, this study explored PDCD4 expression in human follicular-cell-derived thyroid neoplastic lesions. PDCD4 protein expression was semiquantitatively assessed in 100 consecutive thyroid tumors (25 follicular adenomas (FA), 25 follicular carcinomas (FC), 25 papillary carcinomas (PC), and 25 poorly-differentiated/anaplastic cancers (PD-AC)). Twenty-five additional nonneoplastic thyroid tissue samples were included as controls. To further support the data, miR-21 expression was tested (by qRT-PCR and in situ hybridization) in a different series of 75 cases (15 FAs, 15 FCs, 15 PCs, 15 PD-ACs, and 15 controls). Nonneoplastic thyrocytes consistently featured a strong nuclear PDCD4 expression, while the protein's expression was significantly downregulated in neoplastic epithelia. PDCD4 downregulation was significantly associated with less well-differentiated cancer phenotypes (p < 0.001) and more advanced tumor stages (p < 0.001). Consistently with PDCD4 downregulation, miR-21 was upregulated in neoplastic by comparison with nonneoplastic tissue samples. The present results provide evidence of PDCD4 having a role in thyroid carcinogenesis; further studies should investigate the diagnostic value and the prognostic impact of PDCD4 in thyroid neoplasia.
Authors:
Gianmaria Pennelli; Matteo Fassan; Caterina Mian; Marco Pizzi; Mariangela Balistreri; Susi Barollo; Francesca Galuppini; Vincenza Guzzardo; Mariarosa Pelizzo; Massimo Rugge
Related Documents :
20006635 - Arsenite suppression of involucrin transcription through ap1 promoter sites in cultured...
8714515 - Distinct positive and negative regulatory elements control neuronal and hepatic transcr...
19913005 - Pax2 and pea3 synergize to activate a novel regulatory enhancer for spalt4 in the devel...
16398215 - Characterisation of the promoter region of the human dna-repair gene rad51.
10330455 - Expression of embryonic fibronectin isoform eiiia parallels alpha-smooth muscle actin i...
2824565 - Fur gene expression as a discriminating marker for small cell and nonsmall cell lung ca...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-5
Journal Detail:
Title:  Virchows Archiv : an international journal of pathology     Volume:  -     ISSN:  1432-2307     ISO Abbreviation:  Virchows Arch.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9423843     Medline TA:  Virchows Arch     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Medicine (DIMED), Surgical Pathology and Cytopathology Unit, University of Padua, Padua, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup.
Next Document:  Preparation of activated carbon from dried pods of Prosopis cineraria with zinc chloride activation ...